Fig. 4
From: New trends in brain tumor immunity with the opportunities of lymph nodes targeted drug delivery
LN-targeted drug delivery activates immune cells and promotes T cell movement into the brain. Through cLNs injection, neoantigen-loaded carriers stimulate the APCs and effector T cells in lymph nodes. Subsequently, the activated T cells enter brain through lymphatic vessels or artery